Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Stem Cell Transplant Strategies for Low-Grade Lymphoma and CLL
NCT00041288Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2001
- Primary completion
- Jan 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide in non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), sponsored by UT Southwestern Medical Center. Started Oct 2001; status: terminated.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00041288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041288.